These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 14503965)

  • 1. High-level factor VIII gene expression in vivo achieved by nonviral liver-specific gene therapy vectors.
    Miao CH; Ye X; Thompson AR
    Hum Gene Ther; 2003 Sep; 14(14):1297-305. PubMed ID: 14503965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo.
    Miao CH; Thompson AR; Loeb K; Ye X
    Mol Ther; 2001 Jun; 3(6):947-57. PubMed ID: 11407909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro.
    Miao CH; Ohashi K; Patijn GA; Meuse L; Ye X; Thompson AR; Kay MA
    Mol Ther; 2000 Jun; 1(6):522-32. PubMed ID: 10933977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naked DNA transfer of Factor VIII induced transgene-specific, species-independent immune response in hemophilia A mice.
    Ye P; Thompson AR; Sarkar R; Shen Z; Lillicrap DP; Kaufman RJ; Ochs HD; Rawlings DJ; Miao CH
    Mol Ther; 2004 Jul; 10(1):117-26. PubMed ID: 15233948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo.
    Riu E; Grimm D; Huang Z; Kay MA
    Hum Gene Ther; 2005 May; 16(5):558-70. PubMed ID: 15916481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic control elements promote long-term expression of human coagulation factor IX gene in hydrodynamically transfected mice.
    Kim HS; Kim JC; Lee YK; Kim JS; Park YS
    J Gene Med; 2011 Jul; 13(7-8):365-72. PubMed ID: 21710610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient delivery of human clotting factor IX after injection of lentiviral vectors in utero.
    Chen XG; Zhu HZ; Gong JL; Li F; Xue JL
    Acta Pharmacol Sin; 2004 Jun; 25(6):789-93. PubMed ID: 15169633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells.
    Wang JM; Zheng H; Sugahara Y; Tan J; Yao SN; Olson E; Kurachi K
    Hum Gene Ther; 1996 Sep; 7(14):1743-56. PubMed ID: 8886845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound enhances gene delivery of human factor IX plasmid.
    Miao CH; Brayman AA; Loeb KR; Ye P; Zhou L; Mourad P; Crum LA
    Hum Gene Ther; 2005 Jul; 16(7):893-905. PubMed ID: 16000070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgene loss and changes in the promoter methylation status as determinants for expression duration in nonviral gene transfer for factor IX.
    Schüttrumpf J; Milanov P; Abriss D; Roth S; Tonn T; Seifried E
    Hum Gene Ther; 2011 Jan; 22(1):101-6. PubMed ID: 20677911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of cis-acting elements for gene expression from nonviral vectors in vivo.
    Ehrhardt A; Peng PD; Xu H; Meuse L; Kay MA
    Hum Gene Ther; 2003 Feb; 14(3):215-25. PubMed ID: 12639302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic levels of human factor VIII and IX using HIV-1-based lentiviral vectors in mouse liver.
    Park F; Ohashi K; Kay MA
    Blood; 2000 Aug; 96(3):1173-6. PubMed ID: 10910939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct comparison of hepatocyte-specific expression cassettes following adenoviral and nonviral hydrodynamic gene transfer.
    Jacobs F; Snoeys J; Feng Y; Van Craeyveld E; Lievens J; Armentano D; Cheng SH; De Geest B
    Gene Ther; 2008 Apr; 15(8):594-603. PubMed ID: 18288213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of human clotting Factor IX without toxicity in mice after vascular delivery of a lentiviral vector.
    Tsui LV; Kelly M; Zayek N; Rojas V; Ho K; Ge Y; Moskalenko M; Mondesire J; Davis J; Roey MV; Dull T; McArthur JG
    Nat Biotechnol; 2002 Jan; 20(1):53-7. PubMed ID: 11753362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
    Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
    J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for hemophilia B with liver-specific element mediated by Rep-RBE site-specific integration system.
    Xu Z; Ye J; Zhang A; Xie L; Shen Q; Xue J; Chen J
    J Cardiovasc Pharmacol; 2015 Feb; 65(2):153-9. PubMed ID: 25295466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increment of hFIX expression with endogenous intron 1 in vitro.
    Zheng B; Qiu XY; Tan M; Xing YN; Lo D; Xue JL; Qiu XF
    Cell Res; 1997 Jun; 7(1):21-9. PubMed ID: 9261559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
    Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
    Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic therapy for hemophiliacs--therapeutic potential and technological limits].
    Michou AI; Christ M; Pavirani A; Mehtali M
    Transfus Clin Biol; 1997; 4(3):251-61. PubMed ID: 9264782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic modification of bone-marrow mesenchymal stem cells and hematopoietic cells with human coagulation factor IX-expressing plasmids.
    Sam MR; Azadbakhsh AS; Farokhi F; Rezazadeh K; Sam S; Zomorodipour A; Haddad-Mashadrizeh A; Delirezh N; Mokarizadeh A
    Biologicals; 2016 May; 44(3):170-7. PubMed ID: 26928674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.